Northera (droxidopa) Capsules Trademark Details

Northera (Droxidopa) Capsules was registered on Tuesday, January 19, 2016 and is currently owned by Lundbeck NA Ltd. under the registration number 4890294 . This mark is alive with a status of Registered. The last case file activity for this mark occured 8 years ago on Tuesday, January 19, 2016, according to the United State Patent & Trademark Office
Word Mark Northera (Droxidopa) Capsules
Status Alive Registered 700 — Registered

Current Owner

Lundbeck NA Ltd. of Deerfield, IL

View all trademarks for Lundbeck NA Ltd.
Other Trademarks for Lundbeck NA Ltd.
Serial Number 86413124
Registration Number 4890294
Status Date Tuesday, January 19, 2016
Filing Date Tuesday, January 19, 2016
Registration Date Tuesday, January 19, 2016
Attorney Claudia A. Smith

Correspondent

CLAUDIA A. SMITH
WHITE & CASE LLP
1155 AVENUE OF THE AMERICAS
NEW YORK, NY 10036-2711

Case File Statements

Indication of Colors The color(s) slate grey, blue, grey and light grey is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text "(Droxidopa) Capsules"
Description of Mark The mark consists of the wording "NORTHERA" in slate grey on one line, "(DROXIDOPA) CAPSULES" in blue on another line. In the upper right are four slightly overlapping stylized figures of a person in slate grey, blue, grey, and light grey in an arc. The white background represents transparent areas only and is not a feature of the mark.
Goods & Services Pharmaceutical and veterinary preparations, sanitary preparations for medical purposes; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes; All of the above referenced goods containing in significant part DROXIDOPA
Translation of Words in Mark The wording "NORTHERA" has no meaning in a foreign language.

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, October 9, 2014
First Use Anywhere Thursday, December 11, 2014
First Use In Commerce Thursday, December 11, 2014
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.